Rocket Pharmaceuticals (NASDAQ:RCKT – Get Free Report)‘s stock had its “outperform” rating reaffirmed by research analysts at Wedbush in a research report issued on Wednesday, Benzinga reports. They presently have a $15.00 target price on the biotechnology company’s stock. Wedbush’s target price indicates a potential upside of 339.88% from the stock’s previous close. A number […]

BTIG Research reissued their buy rating on shares of NRx Pharmaceuticals (NASDAQ:NRXP – Free Report) in a research note issued to investors on Monday morning,Benzinga reports. BTIG Research currently has a $10.00 price objective on the stock. NRXP has been the subject of several other reports. HC Wainwright reissued a “buy” rating on shares of […]

BTIG Research reaffirmed their buy rating on shares of Invivyd (NASDAQ:IVVD – Free Report) in a research report report published on Monday morning,Benzinga reports. Other equities research analysts have also recently issued research reports about the stock. HC Wainwright reissued a “buy” rating on shares of Invivyd in a report on Tuesday, August 18th. Cantor […]

Rocket Pharmaceuticals (NASDAQ:RCKT – Get Free Report) was upgraded by research analysts at Needham & Company LLC from a “hold” rating to a “buy” rating in a research note issued to investors on Wednesday, MarketBeat reports. The firm presently has a $9.00 target price on the biotechnology company’s stock. Needham & Company LLC’s price target […]